Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,999 | 66,104 | 70,903 | 75,178 | 79,506 |
| TOTAL | $61,322 | $67,260 | $72,497 | $77,070 | $81,836 |
| Non-Current Assets | |||||
| PPE Net | 339 | 312 | 338 | 353 | 395 |
| Intangibles | 11,148 | 11,148 | 11,148 | 11,148 | 11,148 |
| Other Non-Current Assets | 446 | 81 | 107 | 131 | 155 |
| TOTAL | $11,933 | $11,541 | $11,593 | $11,632 | $11,698 |
| Total Assets | $73,255 | $78,801 | $84,090 | $88,702 | $93,534 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,859 | 4,834 | 3,622 | 3,656 | 3,350 |
| TOTAL | $5,859 | $4,834 | $3,622 | $3,656 | $3,350 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,037 | 1,302 | 1,475 | 3,787 | 5,484 |
| TOTAL | $1,037 | $1,302 | $1,475 | $3,787 | $5,484 |
| Total Liabilities | $6,896 | $6,136 | $5,097 | $7,443 | $8,834 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 76 | 76 | 76 | 76 | 76 |
| Common Shares | 29 | 29 | 29 | 29 | 29 |
| Retained earnings | -86,454 | -79,677 | -72,810 | -69,984 | -65,605 |
| Other shareholders' equity | 22 | 53 | 41 | 39 | 45 |
| TOTAL | $66,359 | $72,665 | $78,993 | $81,259 | $84,700 |
| Total Liabilities And Equity | $73,255 | $78,801 | $84,090 | $88,702 | $93,534 |